Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital Markets lifts easyJet to 'outperform'

(Sharecast News) - RBC Capital Markets upgraded easyJet on Tuesday to 'outperform' from 'sector perform' and lifted the price target to 650p from 570p saying it's expecting FY26 profit progress to surprise to the upside. "We see easyJet as well positioned in an environment of strong UK travel demand, amplified fuel and FX tailwinds, and firm forecasts from FY26E," the bank said.

RBC said it also expects a stronger contribution from easyJet's own medium-term profit measures in FY26E (reducing winter losses, upgauging to lower unit-cost A320/1neos aircraft, Holidays growth).

It said that both RBC Elements website activity and Barclaycard spend trends data indicate strong UK travel demand.

RBC said that neither it nor consensus credit easyJet for delivery of its medium term £1bn headline pre-tax profit target, so only above-expected progress is required to prompt upgrades.

The bank said it now forecasts headline pre-tax profit of £791m, around 3% ahead of consensus of £762m in FY26E.

At 1010 BST, the shares were up 0.5% at 582p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.